<DOC>
	<DOC>NCT00538629</DOC>
	<brief_summary>Investigation of the impact of Zeldox on metabolic parameters in patients with bipolar disorder or with schizophrenia and the impact of the treatment with quality of life.</brief_summary>
	<brief_title>Noninterventional Study in Bipolar Disorder and Schizophrenia With Zeldox</brief_title>
	<detailed_description>Observational survey consecutive patient sampling.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Manic and mixed episodes of up to moderate severity in patients with type I and II bipolar disorder and schizophrenia; either first diagnosed or repeated episodes. Patients with a history of hypersensitivity to Ziprasidone. Previous insufficiency of the ZiprasidoneÂ´s treatment. The break of the previous therapeutic condition.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>